oral glp-1 reviews The first weight-loss pill just arrived—and it's not what you might expect. Foundayo hit the market in April 2026 with some surprising differences: no injections, no fasting rules, and clinical Natural GLP-1 Support & Cravings

On 21 May 2026 , Lilly published the long-awaited topline results from the TRIUMPH-1 Phase 3 trial, and the data is striking: participants on the highest dose lost an average of 28.3% of their body weight at 80 weeks , with 45.3% of patients losing 30% or more a threshold previously only achievable with bariatric surgery

Liraglutide is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist

Oral levothyroxine is notoriously difficult to absorb, and factors like food, coffee, supplements, and gut issues can all reduce how much medication actually gets into your system

Both companies are also developing oral versions of GLP-1 medications

Cytotoxicity profiling of designer peptides is crucial to ensure that they are generally safe and do not harm healthy cells while maintaining therapeutic efficacy

Once you select your preferred medication and pay for the first month, you log into the Embody GLP-1 patient portal to complete a full medical intake form